ImprimisRx NJ

FDA Regulatory Profile

Summary

Total Recalls
3
510(k) Clearances
0
Inspections
6
Compliance Actions
2

Recent Recalls

NumberClassProductDate
D-0060-2023Class IITimolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, November 9, 2022
D-1579-2019Class IITimolol- Dorzolamide- Latanoprost P-F (0.5/2.0/0.005%) ophthalmic drops, packaged in 5mL bottles, RxJuly 17, 2019
D-1578-2019Class IITimolol-Latanoprost P-F (0.5/0.005%) ophthalmic drops, packaged in 5mL bottles, Rx only, ImprimisRX July 17, 2019